BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28560574)

  • 21. Clinical evaluation of whole-body oncologic PET with time-of-flight and point-spread function for the hybrid PET/MR system.
    Shang K; Cui B; Ma J; Shuai D; Liang Z; Jansen F; Zhou Y; Lu J; Zhao G
    Eur J Radiol; 2017 Aug; 93():70-75. PubMed ID: 28668434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of time of flight and point spread function on quantitative parameters of lung lesions in
    Huang K; Feng Y; Liang W; Li L
    BMC Med Imaging; 2021 Nov; 21(1):169. PubMed ID: 34773998
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Fledelius J; Winther-Larsen A; Khalil AA; Bylov CM; Hjorthaug K; Bertelsen A; Frøkiær J; Meldgaard P
    J Nucl Med; 2017 Dec; 58(12):1931-1937. PubMed ID: 28490472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
    Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
    Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
    Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
    J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST).
    Ding Q; Cheng X; Yang L; Zhang Q; Chen J; Li T; Shi H
    J Thorac Dis; 2014 Jun; 6(6):677-83. PubMed ID: 24976990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
    Enilorac B; Lasnon C; Nganoa C; Fruchart C; Gac AC; Damaj G; Aide N
    J Nucl Med; 2018 Jul; 59(7):1049-1055. PubMed ID: 29242403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
    Shang J; Ling X; Zhang L; Tang Y; Xiao Z; Cheng Y; Guo B; Gong J; Huang L; Xu H
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1945-53. PubMed ID: 27236466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.
    Rogasch JM; Hofheinz F; Lougovski A; Furth C; Ruf J; Großer OS; Mohnike K; Hass P; Walke M; Amthauer H; Steffen IG
    EJNMMI Phys; 2014 Dec; 1(1):12. PubMed ID: 26501454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
    Teoh EJ; McGowan DR; Macpherson RE; Bradley KM; Gleeson FV
    J Nucl Med; 2015 Sep; 56(9):1447-52. PubMed ID: 26159585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.
    Fledelius J; Khalil A; Hjorthaug K; Frøkiær J
    EJNMMI Res; 2016 Dec; 6(1):71. PubMed ID: 27655428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method for evaluation of patient-specific lean body mass from limited-coverage CT images and its application in PERCIST: comparison with predictive equation.
    Shang J; Tan Z; Cheng Y; Tang Y; Guo B; Gong J; Ling X; Wang L; Xu H
    EJNMMI Phys; 2021 Feb; 8(1):12. PubMed ID: 33555478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of both time of flight and point spread function in brain PET image reconstruction.
    Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Apr; 37(4):422-7. PubMed ID: 26637071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?
    Rendl G; Schweighofer-Zwink G; Sorko S; Gallowitsch HJ; Hitzl W; Reisinger D; Pirich C
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Often Do We Fail to Classify the Treatment Response with [
    Mattoli MV; Calcagni ML; Taralli S; Indovina L; Spottiswoode BS; Giordano A
    Mol Imaging Biol; 2019 Dec; 21(6):1210-1219. PubMed ID: 30850971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF).
    Rogasch JM; Suleiman S; Hofheinz F; Bluemel S; Lukas M; Amthauer H; Furth C
    EJNMMI Phys; 2020 Jan; 7(1):2. PubMed ID: 31925574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
    Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
    Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
    Vennart NJ; Bird N; Buscombe J; Cheow HK; Nowosinska E; Heard S
    Nucl Med Commun; 2017 Jun; 38(6):471-479. PubMed ID: 28394818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.